Vagally-mediated atrial fibrillation in dogs: conversion with bretylium tosylate

Whittington, 1979, An effective conscious model of atrial fibrillation, Cardiovasc Res, 13, 105, 10.1093/cvr/13.2.105

Platou, 1982, Class III antiarrhythmic action in experimental atrial fibrillation and flutter in dogs, J Cardiovasc Pharmacol, 4, 839, 10.1097/00005344-198209000-00021

Loomis, 1955, Auricular fibrillation induced and maintained in animals by acetylcholine or vagal stimulation, Circ Res, 3, 390, 10.1161/01.RES.3.4.390

Burn, 1955, The production of block and auricular fibrillation in the heart-lung preparation by inhibitors of cholinesterase, Br Heart J, 17, 431, 10.1136/hrt.17.4.431

Burn, 1955, The effects of acetylcholine in the heart-lung preparation including production of auricular fibrillation, J Physiol, 128, 277, 10.1113/jphysiol.1955.sp005306

Burn, 1956, The effect of KCl on atrial fibrillation caused by acetylcholine, Circ Res, 4, 288, 10.1161/01.RES.4.3.288

Bacaner, 1966, Bretylium tosylate for suppression of induced ventricular fibrillation, Am J Cardiol, 17, 528, 10.1016/0002-9149(66)90244-X

Bacaner, 1968, Quantitative comparison of bretylium with other antifibrillatory drugs, Am J Cardiol, 21, 504, 10.1016/0002-9149(68)90282-8

Heissenbuttel, 1979, Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias, Ann Intern Med, 91, 229, 10.7326/0003-4819-91-2-229

Leveque, 1965, Anti-arrhythmic action of bretylium, Nature (London), 207, 203, 10.1038/207203a0

Garrey, 1914, The nature of fibrillatory contraction of the heart — its relation to tissue mass and form, Am J Physiol, 33, 397, 10.1152/ajplegacy.1914.33.3.397

Cushny, 1911, Irregularity of the heart and auricular fibrillation, Am J Med Sci, 141, 826, 10.1097/00000441-191106000-00004

Lewis, 1921, Observations upon flutter and fibrillation. Part VII. The effects of vagal stimulation, Heart, 8, 141

Nahum, 1940, Production of auricular fibrillation by application of acetyl-beta-methylcholine chloride to localized regions on the auricular surface, Am J Physiol, 129, 428

Gilmore, 1962, Mechanism of the myocardial effects of bretylium, Circ Res, 10, 347, 10.1161/01.RES.10.3.347

Bacaner, 1984, Differentiation of antifibrillatory vs antiarrhythmic drug actions by their effect on membrane currents, 43, 810

Gokhale, 1963, Mechanism of the initial adrenergic effects of bretylium and guanethidine, Br J Pharmacol, 20, 362

Mirro, 1981, Electrophysiologic properties of bretylium tosylate on atrial myocardium, J Cardiovasc Pharmacol, 3, 1312, 10.1097/00005344-198111000-00019

Schreiber, 1984, Interaction of bretylium tosylate with rat cardiac muscarinic receptors. Possible pharmacological relevance to antiarrhythmic action, Circ Res, 55, 653, 10.1161/01.RES.55.5.653

Cannata, 1958, Clinical observations on the role of the vegetative nervous system in the pathogenesis of atrial fibrillation, Cardiologia, 32, 329, 10.1159/000165836

Coumel, 1978, Syndrome d'arythmie auriculaire d'origine vagale, Arch Mal Coeur, 71, 645